Polydatin Inhibits Nuclear ZEB1 Induction-Provoked Epithelial Mesenchymal Transition to Reduce Fructose-Induced Liver Fibrosis

Xiaojuan Zhao,Yan‐Zi Yang,Hanwen Yu,Wen‐Yuan Wu,Ying Pan,Lin-Lin Kang,Yang Sun,Ling-Dong Kong
DOI: https://doi.org/10.2139/ssrn.3386276
2019-01-01
SSRN Electronic Journal
Abstract:Background: As an epithelial-mesenchymal transition (EMT) inducer, zinc finger E-box binding homeobox 1 (ZEB1) mediates microRNA203 (miR-203) expression. Polydatin can reduce liver fibrosis in experimental animals. However, the underlying mechanisms of fructose-driven liver fibrosis and the action of polydatin are still not clearly understood. Methods: Rats were fed 10% fructose solution for 13 weeks with supplement of polydatin during the last 7 weeks, then examined the effects on liver fibrosis. BRL-3A cells exposed to 5 mM fructose were co-cultured with ZEB1, survivin or transforming growth factor (TGF-β1) siRNA silencing, or miR-203 mimic transfection, at presence or absence of polydtain, then determined the actions on hepatocyte EMT. Findings: Fructose was found to increase nuclear ZEB1 protein level, decrease miR-203 expression, increase survivin, activate TGF-β1/Smad signaling, down-regulate E-cadherin and up-regulate fibroblast specific protein 1 (FSP1), vimentin, N-cadherin and COL1A1 in rat livers and BRL3A cells, in parallel with hepatocyte EMT. Furthermore, nuclear ZEB1 induction-mediated miR-203 low-expression could target survivin to activate TGF-β1/Smad signaling, causing the EMT in BRL-3A cells. Polydatin antagonized nuclear ZEB1 induction to up-regulate miR-203, subsequently block survivin-activated TGF-β1/Smad signaling, which were consistent with its protection from fructose-induced EMT and liver fibrosis. Interpretation: Nuclear ZEB1 induction plays an essential role in fructose-induced EMT in liver fibrosis by targeting survivin to activate TGF-β1/Smad signaling. Suppression of nuclear ZEB1 induction by polydatin is a novel therapeutic strategy for attenuating the EMT in liver fibrosis associated with high fructose diet. Funding Statement: Grant from National Natural Science Foundation of China (No. 81573667 and 81730105).Declaration of Interests: The authors have declared that no competing interest exists. Ethics Approval Statement: All animal experiments were conducted with the approval of the Institutional Animal Care and Use Committee of Nanjing University.
What problem does this paper attempt to address?